All In MedTech

Device Trial Radar · NCT07660185

A Clinical Study of X-Clip Mitral Valve Clip System and Steerable Guide System for Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation

A Pre-Market, Prospective, Single-Arm, Open-Label Clinical Study of X-Clip Mitral Valve Clip System and Steerable Guide System for Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation

Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Mar 1, 2027

Primary completion

May 31, 2028

Study completion Aug 31, 2032

Sponsor

Lead sponsor
Shenzhen Lifevalve Medical Scientific Co., Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
Lifetech Scientific (Shenzhen) Co., Ltd.
First posted
Jun 22, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Shenzhen Lifevalve Medical Scientific Co., Ltd. has developed a new X-Clip Mitral Valve Clip System and its compatible Steerable Guide System, aiming to provide transcatheter mitral valve repair for patients with degenerative mitral regurgitation. The two systems have completed all preclinical tests, including design verification tests, biological evaluation, and animal studies. All the test results confirmed that the systems met relevant design requirements. A First-in-Man clinical study was conducted in China in 2023, involving 11 patients. The study provides initial evidence that the X-Clip Mitral Valve Clip System and Steerable Guide System demonstrate favourable safety and efficacy in the treatment of mitral regurgitation in the Chinese population. The device is currently undergoing a pivotal clinical trial in China. This study is a clinical study aimed to evaluate the safety and performance of the X-Clip Mitral Valve Clip System and Steerable Guide System in European population.

Conditions

  • Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation

Interventions

  • X-Clip Treatment for Degenerative Mitral RegurgitationDevice

    Adult patients with moderate-to-severe or severe primary/degenerative mitral regurgitation (MR ≥3+) undergoing transcatheter mitral valve repair using the X-Clip Mitral Valve Clip System.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of major adverse events (MAEs) within 30 days after operationTime frame: At pre-discharge, 30 days ± 7 days post-procedure

1 more outcomes with a free account

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital Clinic de Barcelona

    Barcelona, Spain

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.